文献速递心力衰竭与心肌病

新型冠状病毒病(COVID-19)患者的心脏受累

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).
PubMed 文献 · JAMA Cardiol · 2020-01-01

本文报告1例既往健康的53岁女性,在COVID-19发热、干咳一周后出现乏力及心力衰竭症状,无呼吸道受累表现。检查示弥漫性ST段抬高、肌钙蛋白T与NT-proBNP升高,心脏磁共振提示双心室水肿、弥漫晚钆增强及左室射血分数35%,符合急性心肌心包炎;经多巴酚丁胺、抗病毒药、激素、氯喹及心衰治疗后逐步稳定。

要点

  • COVID-19可在无间质性肺炎表现时出现急性心肌心包炎。
  • 发热干咳后新发乏力、低血压及心衰表现需警惕心脏受累。
  • 心脏磁共振的双心室水肿与晚钆增强支持心肌炎诊断。

核心结论

  • COVID-19相关心脏受累可作为并发症出现,即使没有间质性肺炎的症状和体征。

研究设计与样本

  • 个案报告:1例53岁既往健康女性,2020年3月因急性心肌心包炎伴收缩功能障碍收入心脏监护病房。

主要发现

  • 心电图示弥漫性ST段抬高,高敏肌钙蛋白T与NT-proBNP升高,胸片正常,冠状动脉造影无阻塞性病变。
  • 心脏磁共振示室壁增厚、弥漫性双心室运动减弱(以心尖段为著)、左室射血分数35%,双心室心肌间质水肿及弥漫晚钆增强,伴环周心包积液。
  • 经多巴酚丁胺、洛匹那韦/利托那韦、激素、氯喹及心衰治疗后临床与仪器指标逐步稳定。

临床怎么用

  • 对COVID-19患者在呼吸道症状后出现乏力、低血压或心衰表现时,应评估心肌损伤标志物与影像学以识别心肌心包炎。

局限性

  • 为单个病例报告,结论外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Virus infection has been widely described as one of the most common causes of myocarditis. However, less is known about the cardiac involvement as a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. OBJECTIVE: To describe the presentation of acute myocardial inflammation in a patient with coronavirus disease 2019 (COVID-19) who recovered from the influenzalike syndrome and developed fatigue and signs and symptoms of heart failure a week after upper respiratory tract symptoms. DESIGN, SETTING, AND PARTICIPANT: This case report describes an otherwise healthy 53-year-old woman who tested positive for COVID-19 and was admitted to the cardiac care unit in March 2020 for acute myopericarditis with systolic dysfunction, confirmed on cardiac magnetic resonance imaging, the week after onset of fever and dry cough due to COVID-19. The patient did not show any respiratory involvement during the clinical course. EXPOSURE: Cardiac involvement with COVID-19. MAIN OUTCOMES AND MEASURES: Detection of cardiac involvement with an increase in levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity troponin T, echocardiography changes, and diffuse biventricular myocardial edema and late gadolinium enhancement on cardiac magnetic resonance imaging. RESULTS: An otherwise healthy 53-year-old white woman presented to the emergency department with severe fatigue. She described fever and dry cough the week before. She was afebrile but hypotensive; electrocardiography showed diffuse ST elevation, and elevated high-sensitivity troponin T and NT-proBNP levels were detected. Findings on chest radiography were normal. There was no evidence of obstructive coronary disease on coronary angiography. Based on the COVID-19 outbreak, a nasopharyngeal swab was performed, with a positive result for SARS-CoV-2 on real-time reverse transcriptase-polymerase chain reaction assay. Cardiac magnetic resonance imaging showed increased wall thickness with diffuse biventricular hypokinesis, especially in the apical segments, and severe left ventricular dysfunction (left ventricular ejection fraction of 35%). Short tau inversion recovery and T2-mapping sequences showed marked biventricular myocardial interstitial edema, and there was also diffuse late gadolinium enhancement involving the entire biventricular wall. There was a circumferential pericardial effusion that was most notable around the right cardiac chambers. These findings were all consistent with acute myopericarditis. She was treated with dobutamine, antiviral drugs (lopinavir/ritonavir), steroids, chloroquine, and medical treatment for heart failure, with progressive clinical and instrumental stabilization. CONCLUSIONS AND RELEVANCE: This case highlights cardiac involvement as a complication associated with COVID-19, even without symptoms and signs of interstitial pneumonia.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. PMID: 32219357. doi:10.1001/jamacardio.2020.1096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。